US FDA Wants Generic Sponsors To Know If Anything Missing Before Submitting ANDA
Executive Summary
Proposed assessment system upgrade would add automation to potentially reduce refuse-to-file actions and review cycles.
You may also be interested in...
US FDA Developing Database Of Medical Review Decisions, Gottlieb Tells Congress
'Knowledge management platform' will identify agency's scientific precedents; Commissioner Gottlieb says it is one of FDA's top three initiatives, along with continuous manufacturing and real-time safety monitoring.
At US Generic Association Annual Meeting, Worries About Sustainability
ANDA sponsors fret price erosion – and potential changes to 180-day exclusivity.
Trump's Budget Surprise: FDA Gains 13% Increase
President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.